DEF: Interparfums Annual Meeting Proxy Statement Filed

Interparfums, Inc. has filed its proxy statement for the September 15, 2026 annual meeting, detailing director elections, executive compensation, and a stock option plan extension.

Summary

• Interparfums, Inc. is holding its Annual Meeting of Shareholders on September 15, 2026, to elect a Board of Directors, vote on executive compensation, and approve a 10-year extension of the 2016 Stock Option Plan.
• The Board of Directors will consist of nine members, with nominees including current directors and two new proposed directors, Valerie Hermann and Bndicte Epinay.
• Shareholders will vote on an advisory resolution to approve executive compensation for named executive officers.
• The company is seeking shareholder approval to extend the 2016 Interparfums, Inc. Stock Option Plan for ten years, until June 27, 2036.
• The record date for determining shareholders entitled to vote is July 22, 2026.
• Key shareholders, including Jean Madar and Philippe Benacin, hold significant beneficial ownership and intend to vote in favor of the director nominees and proposals.
• The company has appointed Grant Thornton, LLP as its new independent registered public accounting firm, replacing Forvis Mazars, LLP.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral; it's a standard proxy statement outlining routine corporate governance matters and upcoming shareholder votes, with no significant unexpected positive or negative developments.

Positives

• The proposed extension of the Stock Option Plan aims to retain and attract key personnel, supporting long-term growth.
• The company has a clear process for director nominations, considering diversity of background and expertise.
• The Board of Directors has adopted a Code of Conduct and a board diversity policy.
• The company maintains a clawback policy for erroneously awarded executive compensation.
• The company has a consistent dividend policy, with increases in recent years and a maintained quarterly dividend.
• The company has a robust insider trading policy and anti-hedging policy to ensure compliance and ethical conduct.

Negatives

• The company notes that finding qualified nominees to serve as a director has been challenging due to the company's size compared to larger competitors.
• The company's Audit Committee does not have an audit committee financial expert as defined by SEC rules, though the board believes the committee members are qualified.
• The company experienced disappointing sales and results for its United States-based operations in 2025, impacting executive compensation adjustments.
• The company's stock performance has lagged behind the NASDAQ Composite and its peer group over the past five years, particularly in 2025.

Risks

• The company faces challenges in attracting and retaining qualified directors due to its size relative to larger industry players.
• Potential for resistance from directors regarding being named as an audit committee financial expert due to perceived additional personal liability.
• Disappointing sales and results in the US operations in 2025 have influenced executive compensation decisions.
• The company's stock performance has shown a decline in 2025 compared to previous years and its peer group.

Future Outlook

The company is seeking to extend its 2016 Stock Option Plan for another 10 years, indicating a continued strategy of using equity incentives to attract and retain talent, which is crucial for future growth and performance.

Management Comments

• The Board of Directors believes that the company's executive compensation packages strike a balance between offering sufficient compensation to retain or attract executives and maintaining compensation at reasonable levels, given the company's resources compared to larger cosmetic giants.
• Management believes that options and SARs granted under the 2016 Option Plan should qualify for the performance-based compensation exception to Section 162(m) of the Internal Revenue Code.
• The Board of Directors is comfortable with the current leadership structure where Jean Madar oversees US operations and Philippe Benacin oversees European operations, as they are also the largest beneficial stockholders.

Industry Context

StockSavvy.ai notes that Interparfums' focus on extending its stock option plan aligns with industry practices aimed at incentivizing key personnel in the competitive fragrance and cosmetics sector. The company's stated need to balance compensation with available resources, compared to larger players like Estee Lauder or LVMH, highlights its strategic positioning.

Comparison to Industry Standards

• The company's peer group for Total Shareholder Return (TSR) comparison includes major players like Coty Inc., e.l.f. Beauty, Inc., The Estee Lauder Companies Inc., L'Oréal SA, LVMH Mot Hennessy Louis Vuitton, Natura &Co Holding SA, Olaplex Holdings, Inc., Procter & Gamble Co., and Shiseido Co Ltd.
• The company's stock performance (TSR) in 2025 was 156.51, compared to the peer group's 89.68 and the NASDAQ Composite's 187.14.
• The company's Net Income performance in 2025 was $156.51 million, compared to the previous year's $235.65 million.
• The company's CEO to Median Employee Pay Ratio was 27.84 to 1 in 2025, which is generally considered low compared to many large corporations.

Management Changes

Corporate Governance

Related Party Transactions

• Fees paid to Jean Madar Holding SAS for supervising and coordinating services amounted to $2.0 million annually for 2023, 2024, and 2025.
• Mr. Benacin received a base salary of $846,640 in 2025, which included payments of $250,000 to his holding company for services rendered outside the US.
• Interparfums SA made a short-term loan of $24 million to Interparfums, Inc. in March 2024 to fund dividend payments, which was repaid with interest.
• Interparfums Luxury Brands, Inc. loaned the Company $20 million in September 2023 and $12 million in December 2023, both repaid in 2024 with interest, to fund share repurchases and dividends.

Stakeholder Impact

• Shareholders will vote on director elections, executive compensation, and the extension of the stock option plan, directly impacting corporate governance and future incentive structures.
• Employees, particularly in European operations, benefit from a mandatory profit-sharing plan as required by French law.
• The company's dividend policy, which has seen increases and maintenance of quarterly payments, directly benefits shareholders.
• The appointment of new directors, if elected, could bring new perspectives and expertise to the Board, potentially influencing strategic decisions.

Next Steps

• Shareholders to vote on the election of nine directors.
• Shareholders to vote on the advisory resolution to approve executive compensation.
• Shareholders to vote on the ten-year extension of the 2016 Interparfums, Inc. Stock Option Plan.
• The company will hold its Annual Meeting of Shareholders on September 15, 2026.

Key Dates

Recommendation

This filing is a routine proxy statement for an annual meeting and does not contain new material financial information or strategic shifts that would warrant a buy or sell recommendation. The proposals are standard corporate governance items. The company's performance in 2025, particularly in the US, and its stock performance relative to peers suggest a 'hold' position pending further operational improvements and market conditions.

Keywords

Proxy Statement, Annual Meeting, Director Election, Executive Compensation, Stock Option Plan, Corporate Governance, Shareholder Vote, Auditor Change